PMID- 31968252 OWN - NLM STAT- MEDLINE DCOM- 20210317 LR - 20231103 IS - 2211-1247 (Electronic) VI - 30 IP - 3 DP - 2020 Jan 21 TI - Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma. PG - 771-782.e6 LID - S2211-1247(19)31728-0 [pii] LID - 10.1016/j.celrep.2019.12.071 [doi] AB - Lung squamous cell carcinoma (LSCC) is a prevalent form of lung cancer exhibiting distinctive histological and genetic characteristics. Chromosome 3q26 copy number gain (CNG) is a genetic hallmark of LSCC present in >90% of tumors. We report that 3q26 CNGs occur early in LSCC tumorigenesis, persist during tumor progression, and drive coordinate overexpression of PRKCI, SOX2, and ECT2. Overexpression of PRKCI, SOX2, and ECT2 in the context of Trp53 loss is sufficient to transform mouse lung basal stem cells into tumors with histological and genomic features of LSCC. Functionally, PRKCI and SOX2 collaborate to activate an extensive transcriptional program that enforces a lineage-restricted LSCC phenotype, whereas PRKCI and ECT2 collaborate to promote oncogenic growth. Gene signatures indicative of PKCiota-SOX2 and PKCiota-ECT2 signaling activity are enriched in the classical subtype of human LSCC and predict distinct therapeutic vulnerabilities. Thus, the PRKCI, SOX2, and ECT2 oncogenes represent a multigenic driver of LSCC. CI - Copyright (c) 2019 The Author(s). Published by Elsevier Inc. All rights reserved. FAU - Liu, Yi AU - Liu Y AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Yin, Ning AU - Yin N AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Wang, Xue AU - Wang X AD - Department of Health Sciences Research, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Khoor, Andras AU - Khoor A AD - Department of Pathology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Sambandam, Vaishnavi AU - Sambandam V AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Ghosh, Anwesha B AU - Ghosh AB AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Fields, Zoe A AU - Fields ZA AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Murray, Nicole R AU - Murray NR AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. FAU - Justilien, Verline AU - Justilien V AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. Electronic address: justilien.verline@mayo.edu. FAU - Fields, Alan P AU - Fields AP AD - Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL 32224, USA. Electronic address: fields.alan@mayo.edu. LA - eng GR - R01 CA081436/CA/NCI NIH HHS/United States GR - R01 CA140290/CA/NCI NIH HHS/United States GR - R01 CA206367/CA/NCI NIH HHS/United States GR - R03 CA235189/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - United States TA - Cell Rep JT - Cell reports JID - 101573691 RN - 0 (ECT2 protein, human) RN - 0 (Isoenzymes) RN - 0 (Proto-Oncogene Proteins) RN - 0 (SOX2 protein, human) RN - 0 (SOXB1 Transcription Factors) RN - EC 2.7.11.13 (Protein Kinase C) RN - EC 2.7.11.13 (protein kinase C lambda) SB - IM MH - Carcinogenesis/genetics/pathology MH - Carcinoma, Non-Small-Cell Lung/*genetics/pathology MH - Carcinoma, Squamous Cell/*genetics/pathology MH - Cell Line, Tumor MH - Cell Proliferation/genetics MH - Cell Transformation, Neoplastic MH - Chromosomes, Human, Pair 3/*genetics MH - Gene Dosage MH - Gene Expression Regulation, Neoplastic MH - Gene Silencing MH - Humans MH - Isoenzymes/*genetics MH - Lung Neoplasms/*genetics/pathology MH - Male MH - *Oncogenes MH - Protein Kinase C/*genetics MH - Proto-Oncogene Proteins/*genetics MH - SOXB1 Transcription Factors/*genetics MH - Signal Transduction MH - Transcription, Genetic PMC - PMC7238436 MID - NIHMS1551546 OTO - NOTNLM OT - 3q26 copy number gain OT - CNG OT - ECT2 OT - LSCC OT - PRKCI OT - SOX2 OT - lung basal stem cells OT - lung squamous cell carcinoma OT - oncogenic transformation COIS- Declaration of Interests The authors declare no competing interests. EDAT- 2020/01/23 06:00 MHDA- 2021/03/18 06:00 PMCR- 2020/05/20 CRDT- 2020/01/23 06:00 PHST- 2019/10/24 00:00 [received] PHST- 2019/11/27 00:00 [revised] PHST- 2019/12/18 00:00 [accepted] PHST- 2020/01/23 06:00 [entrez] PHST- 2020/01/23 06:00 [pubmed] PHST- 2021/03/18 06:00 [medline] PHST- 2020/05/20 00:00 [pmc-release] AID - S2211-1247(19)31728-0 [pii] AID - 10.1016/j.celrep.2019.12.071 [doi] PST - ppublish SO - Cell Rep. 2020 Jan 21;30(3):771-782.e6. doi: 10.1016/j.celrep.2019.12.071.